A 2026 BD opportunity scan of Betta Pharmaceuticals Co., Ltd, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.

A 2026 BD opportunity scan of Azurity Pharmaceuticals, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.

A 2026 BD opportunity scan of Changchun Genescience Pharmaceutical, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.

NCT07435012 clinical trial report covering TH-07, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07434973 clinical trial report covering Cannabidiol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20260731 clinical trial report covering Urea-13C, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07435051 clinical trial report covering Vancomycin Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20260675 clinical trial report covering UREA, C-14, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07443397 clinical trial report covering Anlotinib Dihydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07442513 clinical trial report covering Etamsylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07443163 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white spac

NCT07444086 clinical trial report covering RBD-7022, Phase 3, endpoints, sponsor, geography, readout timing and development white space.